1 | previously | 15,147 |
2 | hitherto | 244 |
3 | dahl | 87 |
4 | heretofore | 53 |
5 | pf4/h | 7 |
6 | 'fully | 5 |
7 | diabecon | 4 |
8 | scantily | 4 |
9 | 30105 | 2 |
10 | ac-maintained | 2 |
11 | bypassers | 2 |
12 | cardiacally | 2 |
13 | fleetingly | 2 |
14 | follow-up.we | 2 |
15 | hrv.we | 2 |
16 | kuschel | 2 |
17 | lrrei | 2 |
18 | lurk | 2 |
19 | mydriatic-cocktail | 2 |
20 | non-noise | 2 |
21 | nondipper/reverse | 2 |
22 | -2′-ones | 1 |
23 | 0.4-ml | 1 |
24 | 2,567/1,032/90 | 1 |
25 | 20-month-period | 1 |
26 | 27,138 | 1 |
27 | 3,796 | 1 |
28 | 37neuroleptic | 1 |
29 | 39·5°c | 1 |
30 | 57,088 | 1 |
31 | 60μm | 1 |
32 | 6988 | 1 |
33 | 789,096 | 1 |
34 | 8,313 | 1 |
35 | 8199 | 1 |
36 | angiotensin-converting-enzyme-inhibitor | 1 |
37 | anti-abatacept | 1 |
38 | anti-cd3/cd28-stimulated | 1 |
39 | article-original | 1 |
40 | bcds | 1 |
41 | binarily | 1 |
42 | brides-to-be | 1 |
43 | cbt-i/irt | 1 |
44 | cd4cd45ra+ | 1 |
45 | chaos-observer | 1 |
46 | cholinesterase-inhibitor | 1 |
47 | clopidogrel-has | 1 |
48 | clowes | 1 |
49 | controls.an | 1 |
50 | dichorionicity | 1 |
51 | draft-cs+group | 1 |
52 | eju | 1 |
53 | er-positive/er | 1 |
54 | estimate.other | 1 |
55 | europe/usa | 1 |
56 | fapr4-c. | 1 |
57 | gaydos | 1 |
58 | hancock™ | 1 |
59 | je-cv-vaccine | 1 |
60 | je-vaccination | 1 |
61 | je-vaccine | 1 |
62 | laynadier | 1 |
63 | lesbian/bisexuals | 1 |
64 | luminex-only-dsa | 1 |
65 | maisano | 1 |
66 | metho-trexate | 1 |
67 | nanolaminates | 1 |
68 | newly-recognised | 1 |
69 | noel/lowest | 1 |
70 | nonpreviously | 1 |
71 | nontelemetry-equipped | 1 |
72 | not-warfarin | 1 |
73 | nsabp-b06-protocol | 1 |
74 | nvp+tdf/ftc | 1 |
75 | oct-criteria | 1 |
76 | oligo-symptomatic | 1 |
77 | ovariectomized+ghrelin | 1 |
78 | plesiomorphy | 1 |
79 | post-phenylalanine | 1 |
80 | ppi-naïve | 1 |
81 | precuffed | 1 |
82 | quarter-sectioned/crust-frozen | 1 |
83 | quebecers | 1 |
84 | reboxetine-and | 1 |
85 | rt-ew | 1 |
86 | simvastatin-and | 1 |
87 | societies/communities | 1 |
88 | streptococci-positive | 1 |
89 | target/class | 1 |
90 | tcovs | 1 |
91 | thermo-sensing | 1 |
92 | thp-based | 1 |
93 | three-cusp | 1 |
94 | two-hundred-fifteen | 1 |
95 | unscientifically | 1 |
96 | usual-lifestyle | 1 |
97 | whether-as | 1 |
1 | 'fully | 5 |
2 | -2′-ones | 1 |
3 | 0.4-ml | 1 |
4 | 2,567/1,032/90 | 1 |
5 | 20-month-period | 1 |
6 | 27,138 | 1 |
7 | 3,796 | 1 |
8 | 30105 | 2 |
9 | 37neuroleptic | 1 |
10 | 39·5°c | 1 |
11 | 57,088 | 1 |
12 | 60μm | 1 |
13 | 6988 | 1 |
14 | 789,096 | 1 |
15 | 8,313 | 1 |
16 | 8199 | 1 |
17 | ac-maintained | 2 |
18 | angiotensin-converting-enzyme-inhibitor | 1 |
19 | anti-abatacept | 1 |
20 | anti-cd3/cd28-stimulated | 1 |
21 | article-original | 1 |
22 | bcds | 1 |
23 | binarily | 1 |
24 | brides-to-be | 1 |
25 | bypassers | 2 |
26 | cardiacally | 2 |
27 | cbt-i/irt | 1 |
28 | cd4cd45ra+ | 1 |
29 | chaos-observer | 1 |
30 | cholinesterase-inhibitor | 1 |
31 | clopidogrel-has | 1 |
32 | clowes | 1 |
33 | controls.an | 1 |
34 | dahl | 87 |
35 | diabecon | 4 |
36 | dichorionicity | 1 |
37 | draft-cs+group | 1 |
38 | eju | 1 |
39 | er-positive/er | 1 |
40 | estimate.other | 1 |
41 | europe/usa | 1 |
42 | fapr4-c. | 1 |
43 | fleetingly | 2 |
44 | follow-up.we | 2 |
45 | gaydos | 1 |
46 | hancock™ | 1 |
47 | heretofore | 53 |
48 | hitherto | 244 |
49 | hrv.we | 2 |
50 | je-cv-vaccine | 1 |
51 | je-vaccination | 1 |
52 | je-vaccine | 1 |
53 | kuschel | 2 |
54 | laynadier | 1 |
55 | lesbian/bisexuals | 1 |
56 | lrrei | 2 |
57 | luminex-only-dsa | 1 |
58 | lurk | 2 |
59 | maisano | 1 |
60 | metho-trexate | 1 |
61 | mydriatic-cocktail | 2 |
62 | nanolaminates | 1 |
63 | newly-recognised | 1 |
64 | noel/lowest | 1 |
65 | non-noise | 2 |
66 | nondipper/reverse | 2 |
67 | nonpreviously | 1 |
68 | nontelemetry-equipped | 1 |
69 | not-warfarin | 1 |
70 | nsabp-b06-protocol | 1 |
71 | nvp+tdf/ftc | 1 |
72 | oct-criteria | 1 |
73 | oligo-symptomatic | 1 |
74 | ovariectomized+ghrelin | 1 |
75 | pf4/h | 7 |
76 | plesiomorphy | 1 |
77 | post-phenylalanine | 1 |
78 | ppi-naïve | 1 |
79 | precuffed | 1 |
80 | previously | 15,147 |
81 | quarter-sectioned/crust-frozen | 1 |
82 | quebecers | 1 |
83 | reboxetine-and | 1 |
84 | rt-ew | 1 |
85 | scantily | 4 |
86 | simvastatin-and | 1 |
87 | societies/communities | 1 |
88 | streptococci-positive | 1 |
89 | target/class | 1 |
90 | tcovs | 1 |
91 | thermo-sensing | 1 |
92 | thp-based | 1 |
93 | three-cusp | 1 |
94 | two-hundred-fifteen | 1 |
95 | unscientifically | 1 |
96 | usual-lifestyle | 1 |
97 | whether-as | 1 |
1 | cd4cd45ra+ | 1 |
2 | fapr4-c. | 1 |
3 | 2,567/1,032/90 | 1 |
4 | 8,313 | 1 |
5 | 30105 | 2 |
6 | 789,096 | 1 |
7 | 3,796 | 1 |
8 | 27,138 | 1 |
9 | 57,088 | 1 |
10 | 6988 | 1 |
11 | 8199 | 1 |
12 | oct-criteria | 1 |
13 | luminex-only-dsa | 1 |
14 | europe/usa | 1 |
15 | oligo-symptomatic | 1 |
16 | 37neuroleptic | 1 |
17 | nvp+tdf/ftc | 1 |
18 | 39·5°c | 1 |
19 | precuffed | 1 |
20 | ac-maintained | 2 |
21 | nontelemetry-equipped | 1 |
22 | thp-based | 1 |
23 | newly-recognised | 1 |
24 | anti-cd3/cd28-stimulated | 1 |
25 | reboxetine-and | 1 |
26 | simvastatin-and | 1 |
27 | 20-month-period | 1 |
28 | brides-to-be | 1 |
29 | usual-lifestyle | 1 |
30 | je-vaccine | 1 |
31 | je-cv-vaccine | 1 |
32 | post-phenylalanine | 1 |
33 | heretofore | 53 |
34 | non-noise | 2 |
35 | nondipper/reverse | 2 |
36 | metho-trexate | 1 |
37 | streptococci-positive | 1 |
38 | ppi-naïve | 1 |
39 | follow-up.we | 2 |
40 | hrv.we | 2 |
41 | thermo-sensing | 1 |
42 | pf4/h | 7 |
43 | lrrei | 2 |
44 | lurk | 2 |
45 | article-original | 1 |
46 | kuschel | 2 |
47 | dahl | 87 |
48 | mydriatic-cocktail | 2 |
49 | 0.4-ml | 1 |
50 | nsabp-b06-protocol | 1 |
51 | 60μm | 1 |
52 | controls.an | 1 |
53 | two-hundred-fifteen | 1 |
54 | quarter-sectioned/crust-frozen | 1 |
55 | ovariectomized+ghrelin | 1 |
56 | not-warfarin | 1 |
57 | diabecon | 4 |
58 | je-vaccination | 1 |
59 | maisano | 1 |
60 | hitherto | 244 |
61 | three-cusp | 1 |
62 | draft-cs+group | 1 |
63 | er-positive/er | 1 |
64 | estimate.other | 1 |
65 | laynadier | 1 |
66 | chaos-observer | 1 |
67 | angiotensin-converting-enzyme-inhibitor | 1 |
68 | cholinesterase-inhibitor | 1 |
69 | whether-as | 1 |
70 | clopidogrel-has | 1 |
71 | bcds | 1 |
72 | societies/communities | 1 |
73 | -2′-ones | 1 |
74 | nanolaminates | 1 |
75 | clowes | 1 |
76 | lesbian/bisexuals | 1 |
77 | gaydos | 1 |
78 | quebecers | 1 |
79 | bypassers | 2 |
80 | target/class | 1 |
81 | tcovs | 1 |
82 | anti-abatacept | 1 |
83 | cbt-i/irt | 1 |
84 | noel/lowest | 1 |
85 | eju | 1 |
86 | rt-ew | 1 |
87 | plesiomorphy | 1 |
88 | fleetingly | 2 |
89 | binarily | 1 |
90 | scantily | 4 |
91 | cardiacally | 2 |
92 | unscientifically | 1 |
93 | 'fully | 5 |
94 | previously | 15,147 |
95 | nonpreviously | 1 |
96 | dichorionicity | 1 |
97 | hancock™ | 1 |